TWD
CVS icon

True Wealth Design’s CVS Health CVS Stock Holding History

True Wealth Design’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112K Sell
1,085
-80
-7% -$7.14K 0.03% 228
2026
Q1 		$83.7K Buy
1,165
+129
+12% +$9.94K 0.02% 257
2025
Q4 		$82.2K Sell
1,036
-35
-3% -$2.76K 0.02% 218
2025
Q3 		$80.8K Buy
1,071
+654
+157% +$44.8K 0.02% 207
2025
Q2 		$28.8K Sell
417
-667
-62% -$43.7K 0.01% 307
2025
Q1 		$73.5K Buy
1,084
+1,039
+2,309% +$62.2K 0.03% 134
2024
Q4 		$2.03K Sell
45
-933
-95% -$52.3K ﹤0.01% 729
2024
Q3 		$61.5K Sell
978
-2,048
-68% -$119K 0.02% 106
2024
Q2 		$179K Buy
3,026
+158
+6% +$9.88K 0.04% 120
2024
Q1 		$229K Buy
2,868
+13
+0.5% +$993 0.06% 116
2023
Q4 		$225K Buy
2,855
+53
+2% +$3.77K 0.06% 113
2023
Q3 		$196K Hold
2,802
– – 0.07% 115
2023
Q2 		$194K Sell
2,802
-511
-15% -$36.4K 0.07% 113
2023
Q1 		$246K Buy
3,313
+2,795
+540% +$234K 0.1% 114
2022
Q4 		$48.3K Buy
+518
New +$50K 0.02% 149

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

True Wealth Design's CVS Position: Q2 2026 in Review

True Wealth Design reduced its CVS Health (CVS) stake by 6.9% in Q2 2026, selling an estimated $7.14K and leaving 1,085 shares worth $112K. The position accounts for 0.03% of the portfolio, ranked #228.

True Wealth Design first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. The position peaked at $246K in Q1 2023. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • True Wealth Design held 1,085 shares of CVS Health worth $112K as of Q2 2026.
  • True Wealth Design sold 80 CVS Health shares in Q2 2026, an estimated $7.14K.
  • CVS Health made up 0.03% of True Wealth Design's portfolio in Q2 2026, its #228 holding.
  • True Wealth Design first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • True Wealth Design's CVS Health position peaked at $246K in Q1 2023.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.